About two million people in Germany suffer from osteoarthritis of the joints. Because of the high incidence and the often unsatisfactory outcomes, the need for safe and effective orthopaedic treatment methods is very high. Under the pressure of the increasing annual number of joint operations for osteoarthritis (so-called total endoprosthesis, for short: TEP), as well as other surgical procedures such as arthroscopy, and the resulting cost burden on the healthcare system in Germany, there is a huge need for the expansion of existing as well as new conservative treatment methods.

In other words: For medical procedures for preserving the knee joint without requiring surgery. Enter ORTHOGEN Lab Services GmbH. The EOT®II syringe is used in the context of non-surgical treatment for osteoarthritis and joint problems. The patented process enables the attending physician to produce autologous conditioned serum (for short: ACS) using the EOT®II syringe in the laboratory.


    • Avoiding Surgery in 83% of patients with Meniscus Lesions by using EOT®II / Orthokine® Serum.

      The results of a retrospective study assessing the use of the EOT®II system in the treatment of painful meniscal lesions were published recently („Strümper R (2017). Sports Medicine International Open 2017; 1: E200–E205“).

      • Specialists meet in Madrid, Spain, to discuss use of the EOT®II system

        On November 17, 2017, over 70 physicians from private practices and hospitals all over Spain met in Madrid to discuss current applications of the EOT®II system.

      • Orthogen Lab Services Distributionsmeeting Düsseldorf
        • International Distributor’s Meeting
          in Dusseldorf

          The annual International Orthogen Distributor’s Meeting 2017 will take place in Düsseldorf, Germany, from January 19 to 21.

          • ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc
            in Moscow

            ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc in Moscow work together to better treat Osteoarthritis. ORTHOGEN’s innovative EOT®II blood preparation kit is used for the benefit of Gazprom employees in Russia.

            • ORTHOGEN kooperiert mit Chiesi Russland
              in Sachen Vermarktung der EOTII-Spritze

              ORTHOGEN Lab Services GmbH and Chiesi Russia have signed a long-term framework agreement for an exclusive cooperation in Russia.

              • ORTHOGEN SUPPORTS

                On the fringes of the German Congress of Orthopaedics and Traumatology (DKOU) on October 22nd, 2015, in Berlin, Orthogen organised a charity soccer match together with the Bundesliga club Hertha BSC. The Above-40 team of Hertha BSC played orthopaedists and trauma surgeons in the Soccer World in Marienfelde.